Products | Clinical Decision Support | August 05, 2015

ImageSmart

ImageSmart

Related Content

Lantheus announced that the U.S. Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly.
News | FDA
Lantheus Announces the FDA Approval of DEFINITY as Ultrasound Enhancing Agent for Use in Certain Pediatric Cardiovascular Patients

March 6, 2024 — Lantheus Holdings, Inc. (Lantheus), a radiopharmaceutical company, has announced that the U.S. Food and ...

Time March 06, 2024
arrow
Proscia, a software company accelerating the transformation to digital pathology, has announced its receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Concentriq AP-Dx for the purpose of primary diagnosis.
News | FDA
Proscia Receives FDA Clearance for Digital Pathology Software Solution

February 12, 2024 — Proscia, a leading provider of digital and computational pathology solutions, has received 510(k) ...

Time February 12, 2024
arrow
Medical imaging artificial intelligence (AI) company Annalise.ai has announced that results from a pioneering clinical study, which examined whether its technology improves radiologists’ performance, have been published in the journal European Radiology.
News | Artificial Intelligence
Study Shows Annalise Deep Learning System Boosts Radiologist Accuracy and Speed for Head CTs

September 20, 2023 — Medical imaging artificial intelligence (AI) company Annalise.ai has announced that the results ...

Time September 20, 2023
arrow
News | SNMMI
Prostate Cancer Treatment Study at SNMMI 2023 Finds Improved Patient Outcomes with Personalized Dosing

June 29, 2023 — A study presented this week during the 2023 Society of Nuclear Medicine and Molecular Imaging (SNMMI) ...

Time June 29, 2023
arrow
Deciphex, a Dublin, Ireland-based provider of digital pathology software and services, has announced the launch of their Diagnexia service in the United States.
News | Digital Pathology
Deciphex Launches its Diagnostics as a Service (DxaaS) in US

September 13, 2022 — Deciphex, a Dublin, Ireland-based provider of digital pathology software and services, has ...

Time September 13, 2022
arrow
Change Healthcare unveiled InterQual 2021, the latest edition of the company’s flagship clinical decision support solution.
News | Clinical Decision Support
Change Healthcare Launches InterQual 2021 Solution

April 22, 2021 — Change Healthcare unveiled InterQual 2021, the latest edition of the company’s flagship clinical ...

Time April 22, 2021
arrow
Elsevier’s STATdx, a leading radiology diagnostic decision support solution, now includes select Merit-Based Incentive Payment System (MIPS) Measures validated by MDinteractive
News | Clinical Decision Support
Leading Radiology Diagnostic Decision Technology Enhanced for Standardization, Reimbursement

April 2, 2021 — Elsevier, a global leader in research publishing and information analytics, announced a partnership with ...

Time April 02, 2021
arrow
Philips connects oncologists and pathologists around the world to MD Anderson’s Precision Oncology Decision Support (PODS) system of actionable clinical information
News | Clinical Decision Support
Philips and MD Anderson Collaborate to Provide Oncologists with Evidence-based Therapy, Clinical Trial Guidance

June 16, 2020 — Philips and The University of Texas MD Anderson Cancer Center announced a collaboration to provide ...

Time June 16, 2020
arrow
IBM Watson Health and EBSCO Information Services (EBSCO) announced a strategic collaboration aimed toward enhancing clinical decision support (CDS) and operations for healthcare providers and health system
News | Clinical Decision Support
IBM Watson Health and EBSCO Information Services Collaborate to Launch Integrated Clinical Decision Support Solution

March 13, 2020 — IBM Watson Health and EBSCO Information Services (EBSCO) announced a strategic collaboration aimed ...

Time March 13, 2020
arrow
Effective Jan. 1, 2020, new regulations under the Centers for Medicare & Medicaid Services (CMS) Protecting Access to Medicare Act (PAMA) will require physicians to consult a CMS-approved clinical decision support mechanism before ordering advanced imaging exams for fee-for-service Medicare patients
News | Clinical Decision Support
Change Healthcare Announces CareSelect Imaging Open Access

December 26, 2019 — Effective Jan. 1, 2020, new regulations under the Centers for Medicare & Medicaid Services (CMS) ...

Time December 26, 2019
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now